ENTRY       D10409                      Drug
NAME        Quilizumab (USAN/INN)
FORMULA     C6492H10052N1728O2026S44
EXACT_MASS  146044.4372
MOL_WEIGHT  146134.4993
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS DYGIAWVRQA PGKGLEWVAF ISDLAYTIYY
            ADTVTGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCARDN WDAMDYWGQG TLVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSREEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRSSQSLV HNNANTYLHW YQQKPGKAPK LLIYKVSNRF
            SGVPSRFSGS GSGTDFTLTI SSLQPEDFAT YYCSQNTLVP WTFGQGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H96, H144-H200, H220-L219, H226-H'226, H229-H'229, H271-H321, H367-H425, H22'-H'96, H'144-H'200, H'220-L'219, H'261-H'321, H'367-H'425, L23-L93, L139-L199, L'23-L'93, L'139-L'199; Glycosylation site: H297, H'297)
  TYPE      Peptide
EFFICACY    Antiasthmatic
  TYPE      Monoclonal antibody
COMMENT     Treatment of asthma
DBLINKS     CAS: 1228538-47-3
            PubChem: 172232502
///
